BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25869319)

  • 1. A novel formulation of veggies with potent anti-migraine activity.
    Jain MM; Kumari N; Rai G
    Int J Comput Biol Drug Des; 2015; 8(1):54-61. PubMed ID: 25869319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel formulation of veggies with potent liver detoxifying activity.
    Jain MM; Kumari N; Rai G
    Int J Comput Biol Drug Des; 2015; 8(1):75-86. PubMed ID: 25869321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
    Bigal ME; Walter S; Rapoport AM
    Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic antibodies against CGRP or its receptor.
    Bigal ME; Walter S; Rapoport AM
    Br J Clin Pharmacol; 2015 Jun; 79(6):886-95. PubMed ID: 25614243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin gene-related peptide receptor antagonists: new therapeutic agents for migraine.
    Bell IM
    J Med Chem; 2014 Oct; 57(19):7838-58. PubMed ID: 24960305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
    Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
    J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin gene-related peptide (CGRP) antagonists and migraine: is this a new era?
    Goadsby PJ
    Neurology; 2008 Apr; 70(16):1300-1. PubMed ID: 18413584
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent watch: Migraine therapies targeting the CGRP pathway: intellectual property landscape.
    Fiala JL; Lowery D
    Nat Rev Drug Discov; 2016 Jan; 15(1):8-9. PubMed ID: 26669672
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.
    Goadsby PJ
    Drugs; 2005; 65(18):2557-67. PubMed ID: 16392873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
    Maasumi K; Michael RL; Rapoport AM
    Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment.
    Edvinsson L
    Br J Clin Pharmacol; 2015 Aug; 80(2):193-9. PubMed ID: 25731075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CGRP mechanism antagonists and migraine management.
    Karsan N; Goadsby PJ
    Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CGRP: A New Era for Migraine Treatment.
    Wrobel Goldberg S; Silberstein SD
    CNS Drugs; 2015 Jun; 29(6):443-52. PubMed ID: 26138383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CGRP Pathway in Migraine as a Viable Target for Therapies.
    Edvinsson L
    Headache; 2018 May; 58 Suppl 1():33-47. PubMed ID: 29697153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine.
    Benemei S; Nicoletti P; Capone JG; De Cesaris F; Geppetti P
    Handb Exp Pharmacol; 2009; (194):75-89. PubMed ID: 19655105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.
    Pellesi L; Guerzoni S; Pini LA
    Clin Pharmacol Drug Dev; 2017 Nov; 6(6):534-547. PubMed ID: 28409893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting calcitonin gene-related peptide: a new era in migraine therapy.
    Charles A; Pozo-Rosich P
    Lancet; 2019 Nov; 394(10210):1765-1774. PubMed ID: 31668411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.
    Durham PL
    Headache; 2008 Sep; 48(8):1269-75. PubMed ID: 18808507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of novel alpha-Calcitonin Gene-Related Peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors.
    Taylor CK; Smith DD; Hulce M; Abel PW
    J Pharmacol Exp Ther; 2006 Nov; 319(2):749-57. PubMed ID: 16873605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.